Skip to content

Persian honeylocust ointment in hemorrhoids

Evalution of the effect of ointment containing extract of Persian honeylocust(GleditsiaCaspica) on clinical symptoms and quality of life in patients with hemorrhoids: A randomized clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220122053783N1
Enrollment
60
Registered
2022-02-20
Start date
2022-02-21
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoid. Other hemorrhoids

Interventions

Intervention 1: Intervention group: they will receive an ointment containing hydroalcoholic extract of Persian honeylocust (Gleditsia Caspica) 1 gram/two times a day using an applicator for 2 weeks. O

Sponsors

Ardabil University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with grade 1-2 internal hemorrhoids Age 18-65 years Patients with bleeding or hemorrhoidal prolapse or pain or two or all together Have a signed informed consent form to participate in the study

Exclusion criteria

Exclusion criteria: Anorectal diseases such as rectal prolapse, Fisher, fistula, perianal abscess Thrombosis and gangrenous hemorrhoids Uncontrolled cardiovascular disease Cirrhosis Inflammatory bowel disease (IBD) Pregnancy and lactation History of allergy to herbal medicines Use analgesics less than a week ago Use of anticoagulants less than a month ago Use of steroid less than a month ago Unwillingness to participate in the study

Design outcomes

Primary

MeasureTime frame
Pain according to CORECTS questionnaire. Timepoint: At the first (before starting the study), end of the first and the second week. Method of measurement: Colo-Rectal Evaluation of Clinical Therapeutics Scale (CORECTS) questionnaire.;Rectorrhagia according to CORECTS questionnaire. Timepoint: At the fist (before starting the study), end of the first and the second week. Method of measurement: Colo-Rectal Evaluation of Clinical Therapeutics Scale (CORECTS) questionnaire.

Secondary

MeasureTime frame
Itching according to CORECTS questionnaire. Timepoint: At the fist (before starting the study), end of the first and the second week. Method of measurement: Colo-Rectal Evaluation of Clinical Therapeutics Scale (CORECTS) questionnaire.;Quality of Life. Timepoint: At the fist (before starting the study), end of the first and the second week. Method of measurement: The World Health Organization Quality of Life Instrument, Short Form (WHOQOL-BREF) questionnaire.;Possible side effects of treatment. Timepoint: At the fist (before starting the study), end of the first and the second week. Method of measurement: Researcher-made questionnaire.;Satisfaction of treatment. Timepoint: At the fist (before starting the study), end of the first and the second week. Method of measurement: Researcher-made questionnaire (according to Visual Analogue Scale).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArezoo Moini Jazani

Ardabil University of Medical Sciences

dr.moeeni@yahoo.com+98 45 3353 4790

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026